TFF Group (OTCMKTS:FRFTF – Get Free Report) saw a large increase in short interest in July. As of July 15th, there was short interest totaling 13,860 shares, an increase of 334.8% from the June 30th total of 3,188 shares. Based on an average trading volume of 113 shares, the short-interest ratio is currently 122.7 days.
TFF Group Stock Performance
OTCMKTS:FRFTF opened at C$17.50 on Friday. TFF Group has a one year low of C$17.50 and a one year high of C$20.14. The firm has a 50-day simple moving average of C$17.50 and a 200-day simple moving average of C$18.78.
About TFF Group
TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics.
Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines.
Featured Stories
- Five stocks we like better than TFF Group
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for TFF Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TFF Group and related companies with MarketBeat.com's FREE daily email newsletter.
